Jazz Pharmaceuticals plc — Director's Dealing 2012

Aug 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2012-08-09

Reporting Person: Sohn Catherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-09	Ordinary Shares	A	4000	—	Acquired	4000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-09	Option (right to buy)	$46.83	A	8000	Acquired	2022-08-08	Ordinary Shares (8000)	Direct

Footnotes

F1: These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in three equal annual installments on the anniversary of the grant date, August 9, 2012.

F2: This option is granted pursuant to the Issuer's 2007 Equity Incentive Plan and consists of a nonstatutory stock option exercisable for 8,000 ordinary shares. This option vests over three years from the grant date, August 9, 2012, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments thereafter.